HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment.

AuthorsR Nissi, V Kotila, E Knuuti, P O Väre, S Kauppila
JournalThe British journal of dermatology (Br J Dermatol) Vol. 161 Issue 4 Pg. 958-60 (Oct 2009) ISSN: 1365-2133 [Electronic] England
PMID19659469 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • pimecrolimus
  • Tacrolimus
Topics
  • Female
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Keratinocytes (metabolism)
  • Precancerous Conditions (metabolism)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Tacrolimus (analogs & derivatives, therapeutic use)
  • Tumor Suppressor Protein p53 (drug effects, metabolism)
  • Vulvar Lichen Sclerosus (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: